0000899243-20-019047.txt : 20200713
0000899243-20-019047.hdr.sgml : 20200713
20200713215603
ACCESSION NUMBER: 0000899243-20-019047
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200709
FILED AS OF DATE: 20200713
DATE AS OF CHANGE: 20200713
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Plunkett Matthew
CENTRAL INDEX KEY: 0001557551
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39370
FILM NUMBER: 201026228
MAIL ADDRESS:
STREET 1: 3101 WESTERN AVENUE, SUITE 600
CITY: SEATTLE
STATE: WA
ZIP: 98121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nkarta, Inc.
CENTRAL INDEX KEY: 0001787400
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474515206
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6000 SHORELINE COURT
STREET 2: SUITE 102
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-215-0385
MAIL ADDRESS:
STREET 1: 6000 SHORELINE COURT
STREET 2: SUITE 102
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-07-09
0
0001787400
Nkarta, Inc.
NKTX
0001557551
Plunkett Matthew
C/O NKARTA, INC.
6000 SHORELINE COURT, SUITE 102
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Financial Officer
Stock Option (right to buy)
18.00
2020-07-09
4
A
0
77800
0.00
A
2030-07-08
Common Stock
77800
77800
D
This option vests and becomes exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following July 9, 2020. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a "change in control" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or "disability" (as described in the applicable award agreement).
/s/ Matthew Plunkett
2020-07-10